Occurrence, Management, and Risk Factors for Adverse Drug Reactions in Multidrug Resistant Tuberculosis Patients

Nafees Ahmad1, Arshad Javaid2, Syed Azhar Syed Sulaiman1

  • 1Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia.

Insights

Adverse drug reactions (ADRs) are common in multidrug-resistant tuberculosis (MDR-TB) patients in Pakistan, but rarely impact treatment outcomes. Patients with a baseline body weight of 40 kg or more are at higher risk for ADRs.

Area of Science:

  • Infectious Diseases
  • Pharmacovigilance
  • Clinical Medicine

Background:

  • Pakistan faces a significant burden of multidrug-resistant tuberculosis (MDR-TB).
  • Limited data exists on the prevalence, management, and risk factors for adverse drug reactions (ADRs) in Pakistani MDR-TB patients.
  • Understanding ADRs is crucial for optimizing treatment and patient outcomes.

Purpose of the Study:

  • To evaluate the occurrence, management, and risk factors for ADRs in MDR-TB patients in Pakistan.
  • To assess the impact of ADRs on treatment outcomes.
  • To identify patient characteristics associated with increased ADR risk.

Main Methods:

  • An observational cohort study was conducted at a drug-resistant tuberculosis management unit in Peshawar, Pakistan.
  • 181 MDR-TB patients were enrolled between January 2012 and February 2013.
  • Patients were followed until treatment outcomes were reported, with ADRs identified through clinical and laboratory data.

Main Results:

  • A high prevalence of ADRs was observed, with 131 patients (72.4%) experiencing at least one ADR.
  • Gastrointestinal disturbances (42%), psychiatric disturbances (29.3%), arthralgia (24.3%), and ototoxicity (21%) were the most common ADRs.
  • Baseline body weight ≥ 40 kg was the only identified risk factor for ADRs (OR = 2.321, P = 0.013).
  • Potentially life-threatening ADRs like nephrotoxicity (2.7%) and hypokalemia (2.8%) were less common.
  • ADRs led to treatment regimen modification in only 11% of patients and did not negatively impact treatment outcomes.

Conclusions:

  • ADRs are highly prevalent in Pakistani MDR-TB patients but generally do not lead to permanent treatment discontinuation or adverse outcomes.
  • Patients with a baseline body weight of 40 kg or more require closer monitoring for ADRs.
  • This study highlights the need for vigilant monitoring and management of ADRs in MDR-TB treatment programs.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
761
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
162
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
148
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
640
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
167